Proximal Ventures raises debut fund to back startups bringing AI to drug development
Proximal Ventures announced a debut fund of $27.5 million to support startups applying AI to drug development. The fund focuses on early-stage companies in the pharmaceutical sector. This capital injection may accelerate AI-driven discovery and reduce time to market for new therapies.
techcrunch.com